Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/15/2025

Evaluation of Moderate Hepatocellular Liver Injury

Classification and Diagnosis

  • Hepatocellular liver injury is characterized by predominant elevation of aminotransferases (ALT and AST) 2
  • The R value (ratio of ALT/ULN to ALP/ULN) helps classify liver injury patterns, with R ≥5 defining hepatocellular injury 2
  • The American Association for the Study of Liver Diseases recommends classifying ALT/AST elevation as: Mild: <5× upper limit of normal (ULN), Moderate: 5-10× ULN, Severe: >10× ULN 1, 3

Clinical Evaluation and Management

  • Moderate hepatocellular injury warrants further evaluation to determine the underlying cause 1
  • Common causes of this pattern include non-alcoholic fatty liver disease (NAFLD), viral hepatitis, and medication-induced liver injury 1
  • A complete liver panel, viral hepatitis serologies, review of medications, and abdominal ultrasound are recommended for evaluation 1
  • For medication-induced liver injury, consider discontinuing suspected hepatotoxic medications 1
  • For NAFLD, implement lifestyle modifications (weight loss, exercise, dietary changes) 1

Monitoring and Referral

  • Monitor liver enzymes every 2-4 weeks initially to establish trends 1
  • Consider hepatology referral if enzymes remain elevated for ≥6 months or if there is evidence of synthetic dysfunction 1

REFERENCES

2

Evaluation and Management of Mildly Elevated Transaminases [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Elevated Liver Enzymes: Causes and Diagnostic Approach [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025